[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356769-105":59,"doc-detail-356769-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","interrelation-between-lncrna-hotair-and-ezh2-expression-and-progression-free-survival-during-endocrine-treatment-in-breast-cancer","Interrelation between lncRNA HOTAIR and EZH2 expression and progression free survival during endocrine treatment in breast cancer","","Purpose HOTAIR and EZH2 have been identified to interact and to play a role in breast cancer development. This retrospective clinical cohort study analyzes HOTAIR lncRNA and EZH2 mRNA expression to evaluate their combined predictive value in breast cancer. Patients and methods include 1,465 patients treated between 1979 and 1996, with qRT-PCR measurement and survival analysis using Cox regression and Kaplan-Meier methods. Results show associations with ER/HER2 status and evidence of stronger combined prognostic linkage for progression-free survival. Conclusion HOTAIR may predict tamoxifen resistance independently and with EZH2 in ER+/HER2- disease and may serve as a prognostic biomarker.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/interrelation-between-lncrna-hotair-and-ezh2-expression-and-progression-free-survival-during-endocrine-treatment-in-breast-cancer/356769/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/interrelation-between-lncrna-hotair-and-ezh2-expression-and-progression-free-survival-during-endocrine-treatment-in-breast-cancer/356769.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study purpose regarding HOTAIR and EZH2?","Question",{"text":112,"@type":113},"To assess whether HOTAIR lncRNA and EZH2 mRNA expression have combined predictive value as biomarkers in breast cancer during endocrine treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were HOTAIR expression and clinical outcomes measured?",{"text":117,"@type":113},"HOTAIR expression was measured in fresh frozen primary tumor samples using qRT-PCR, and outcomes such as metastasis-free survival and progression-free survival were analyzed using Cox regression, Kaplan-Meier curves, and log-rank tests.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about HOTAIR and EZH2 expression?",{"text":121,"@type":113},"Both were significantly associated with ER and HER2 status, and in specific tamoxifen-treated ER+/HER2- patients, the combination of HOTAIR and EZH2 showed a stronger association with progression-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356769,1790695716,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Huang et al. BMC Cancer (2026) 26:596 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15876-9](https://doi.org/10.1186/s12885-026-15876-9)  \nRESEARCH Open Access  \nInterrelation between lncRNA HOTAIR and EZH2 expression and progression free survival during endocrine treatment in breast cancer  \nZhangzan Huang1†, Camilla Muritti1,2†, Anieta Sieuwerts1^, Vanja de Weerd1, Mieke Timmermans1, John W. M. Martens 1† and Maurice P. H. M. Jansen 1*†  \nAbstract  \nPurpose HOTAIR and EZH2 have been identified to interact and to play a role in breast cancer development. In this retrospective clinical cohort study, HOTAIR lncRNA and EZH2 mRNA expression levels were analyzed to assess their combined value as a predictive marker in breast cancer.  \nPatients and Methods This retrospective study analyzed 1,465 patients with primary resectable breast cancer treated between 1979 and 1996. HOTAIR expression was measured in fresh frozen primary tumor tissue samples using qRT-PCR. Clinicopathological data were collected according to standardized criteria. Statistical analyses included non-parametric tests, logistic and Cox proportional hazards regression, and Kaplan-Meier curves and log-rank tests for survival outcomes (metastasis-free survival (MFS), progression-free survival (PFS), overall survival (OS)) . Two-sided p-values \u003C 0.05 were considered statistically significant.  \nResults HOTAIR and EZH2 expression were both significantly associated with ER and HER2 status, and EZH2 also with age, histological features, and PR status. In 270 ER+/HER2-patients who received tamoxifen as first line treatment, higher expression of each HOTAIR and EZH2 were significantly associated with PFS, meanwhile, the combination of these two associated more strongly with PFS. In treatment-naïve lymph node-negative patients with ER+/HER2-tumors, higher HOTAIR expression was associated with worse MFS and OS with the tertile threshold.  \nConclusion This study suggests that HOTAIR may have predictive value for tamoxifen resistance in ER+/HER2 − breast cancer, both independently and in combination with EZH2 . Our findings further indicate that HOTAIR could potentially serve as a prognostic biomarker in this subtype.  \nKeywords HOTAIR, lncRNAs, EZH2, Breast cancer, Tamoxifen, Endocrine resistance  \n†Zhangzan Huang, Camilla Muritti, John W. M. Martens and Maurice P. H. M. Jansen contributed equally to this work.  \n^Anieta Sieuwerts is deceased.  \n*Correspondence:  \nMaurice P. H. M. Jansen  \n[m.p.h. m.jansen@erasmusmc.nl](m.p.h. m.jansen@erasmusmc.nl)  \n1Department of Medical Oncology, Erasmus MC, Dr. Molewaterplein 40, Rotterdam 3015 GD, Netherlands  \n2Clinical Research MSc, Rotterdam, Netherlands  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nHuang et al. BMC Cancer (2026) 26:596  \nIntroduction  \nBreast cancer represents a major global health challenge, impacting millions of people worldwide a","cbCailaLhwDtWEHE","https://ap.wps.com/l/cbCailaLhwDtWEHE","pdf",1744807,11,"English","# Abstract\n# Introduction\n## Breast cancer subtypes and endocrine therapy\n## Tamoxifen resistance and need for biomarkers\n## Role of HOTAIR","[{\"question\":\"What was the study purpose regarding HOTAIR and EZH2?\",\"answer\":\"To assess whether HOTAIR lncRNA and EZH2 mRNA expression have combined predictive value as biomarkers in breast cancer during endocrine treatment.\"},{\"question\":\"How were HOTAIR expression and clinical outcomes measured?\",\"answer\":\"HOTAIR expression was measured in fresh frozen primary tumor samples using qRT-PCR, and outcomes such as metastasis-free survival and progression-free survival were analyzed using Cox regression, Kaplan-Meier curves, and log-rank tests.\"},{\"question\":\"What did the results show about HOTAIR and EZH2 expression?\",\"answer\":\"Both were significantly associated with ER and HER2 status, and in specific tamoxifen-treated ER+/HER2- patients, the combination of HOTAIR and EZH2 showed a stronger association with progression-free survival.\"}]","Interrelation between lncRNA HOTAIR and EZH2 expression and progression free survival during endocrine treatment in breast cancer | PDF",1790127198,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fadba3145542248d39f9a7ac88070b64.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/361932116ae4c614bd5179c4f63a7614.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/533782babfa30537931090fdf004cb7d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54dc2bb6943760cc912a27085507e4f6.webp",980,1306]